- Home
- INDP vs LAES Comparison
INDP vs LAES Comparison
Compare INDP & LAES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- LAES
- Stock Information
- Founded
- INDP 2000
- LAES 2022
- Country
- INDP United States
- LAES Switzerland
- Employees
- INDP N/A
- LAES N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- LAES Semiconductors
- Sector
- INDP Health Care
- LAES Technology
- Exchange
- INDP Nasdaq
- LAES Nasdaq
- Market Cap
- INDP 5.0M
- LAES 304.2M
- IPO Year
- INDP N/A
- LAES N/A
- Fundamental
- Price
- INDP $11.00
- LAES $3.97
- Analyst Decision
- INDP Strong Buy
- LAES Strong Buy
- Analyst Count
- INDP 2
- LAES 1
- Target Price
- INDP $8.50
- LAES $6.00
- AVG Volume (30 Days)
- INDP 689.8K
- LAES 12.4M
- Earning Date
- INDP 08-11-2025
- LAES 07-15-2025
- Dividend Yield
- INDP N/A
- LAES N/A
- EPS Growth
- INDP N/A
- LAES N/A
- EPS
- INDP N/A
- LAES N/A
- Revenue
- INDP N/A
- LAES $10,981,000.00
- Revenue This Year
- INDP N/A
- LAES N/A
- Revenue Next Year
- INDP N/A
- LAES N/A
- P/E Ratio
- INDP N/A
- LAES N/A
- Revenue Growth
- INDP N/A
- LAES N/A
- 52 Week Low
- INDP $7.56
- LAES $0.29
- 52 Week High
- INDP $66.64
- LAES $11.00
- Technical
- Relative Strength Index (RSI)
- INDP 51.26
- LAES 53.99
- Support Level
- INDP $9.45
- LAES $3.81
- Resistance Level
- INDP $13.44
- LAES $4.64
- Average True Range (ATR)
- INDP 2.06
- LAES 0.32
- MACD
- INDP 0.19
- LAES -0.03
- Stochastic Oscillator
- INDP 28.75
- LAES 44.81
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.